Efficacy of Ofatumumab Greater than Teriflunomide in Early Relapsing MS
Ofatumumab was found to have greater efficacy than teriflunomide for the treatment of patients with newly diagnosed relapsing multiple sclerosis.
Florence Chaverneff, PhD
Editor https://www.neurologyadvisor.com
Florence Chaverneff, PhD, is the editor for Clinical Pain Advisor at Haymarket Media. A neuroscientist by training, Florence conducted basic research investigating mechanisms underlying Alzheimer disease, schizophrenia, and multiple sclerosis, and acquired additional experience in stem cell biology.
